Skip to main content
. 2021 May 25;77(20):2494–2513. doi: 10.1016/j.jacc.2021.03.314

Central Illustration.

Central Illustration

Proposed Mechanistic Effects of Fat-Derived C16:0-Ceramide

Dysfunctional thoracic adipose tissue in obese cardiac patients secretes higher levels of C16:0-ceramide (Cer16:0), increasing its circulating levels. Acting via endothelial nitric oxide synthase signaling, circulating Cer16:0 enhances systemic inflammation, amplifies oxidative stress, and reduces endothelium-dependent vasorelaxation, eventually leading to adverse cardiac outcomes including death.